GLP-1s are among the most expensive weight loss medications, with monthly costs often exceeding $1,000
Its primary use is diluting or reconstituting medications for intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection
Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, OFarrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Milicevic Z (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
When telehealth verification and documented symptom logs are available, patients gain confidence, clinicians get reliable data, and the risk of counterfeit exposure falls